<!doctype html>

*|MC:SUBJECT|*

View this email in your browser
 
 

Register Today for the ASBMR Webinar “Should Vertebral Augmentation Be Paused? A Webinar on the Second ASBMR Task Force Report on the Efficacy and Safety of Vertebral Augmentation”

Vertebral compression fractures are highly prevalent in patients with osteoporosis and approximately 750,000 new fractures occur each year in the United States alone. Acute and chronic back pain occur in approximately one-third of patients with vertebral fractures, resulting in disability and impaired quality of life. Vertebral augmentation (percutaneous vertebroplasty or balloon kyphoplasty) to reduce pain in patients with symptomatic vertebral fractures was introduced into practice before high quality evidence establishing its efficacy and safety and remains in some settings part of standard routine care. Balloon kyphoplasty is currently more expensive and is performed almost three times more commonly than percutaneous vertebroplasty in the United States. This webinar will be held tomorrow, March 29, 2019 at 12:00 PM ET. Click here to register!

 

April Career Development Webinar:
“Making the Most of Virtual Mentorship”

Join us on Thursday, April 18, 3:00 PM EDT for the next Career Development Webinar: “Making the Most of Virtual Mentorship”. Learn how to utilize ASBMR’s new online mentoring platform to network with fellow members. Also, Drs. Lilian Plotkin, Ph.D. and Ursula Heilmeier, M.D. will share their experiences and tips to optimize your online mentoring experience. This webinar is free to attend, so register today!

 
Mentoring Tip #2: Once you've found your mentoring partner, check out the Resources tab in the top navigation for tips, quizzes, activities, and even an eBook on making the most of this partnership! For more information, visit Getting Started & FAQ.
 

Only Two Weeks Left to Submit Your Abstract for ASBMR 2019!
Deadline is April 10th

Time is running out to submit your abstract! Showcase the research you’ve been working on to a global audience of colleagues at the ASBMR 2019 Annual Meeting, taking place September 20–23, 2019 in Orlando, Florida, USA. Submissions are due April 10. Accepted abstracts will be published in the Journal of Bone and Mineral Research (JBMR®, Impact Factor 6.314), the highest-ranked bone journal. Visit the Abstracts page to review the abstract submission instructions before submitting your abstract.

 

*Action Alert*
Urge Your Senator to Add FD/MAS to DOD Research Program

Currently, fibrous dysplasia/McCune-Albright syndrome (FD/MAS) researchers are ineligible to apply for research funding through the Peer Reviewed Medical Research Program, one of the Congressionally Directed Medical Research Programs at the Department of Defense.

People living with FD/MAS—alongside the friends, family, healthcare practitioners, and researchers who care about them—are fighting to change that.

Senator Jeff Merkley of Oregon has authored a sign-on letter in support of adding FD/MAS to the Peer Reviewed Medical Research Program. We urge our US-based members to urge their senators to join Senator Merkley and sign-on to his letter by completing this action alert.

 

Deadline Approaching: Apply for the 2019 Harold M. Frost
Young Investigator Awards by Monday, April 15, 2019!

ASBMR is accepting applications for the 2019 Harold Frost Young Investigator Award. ASBMR will provide up to ten young investigators $1,500 each in travel support based on competitive applications. These awards give young investigators a unique opportunity to present their research and connect with senior investigators at the Orthopaedic Research Society (ORS) 48th International Musculoskeletal Biology Workshop, July 25 – 28, 2019 in Sun Valley, Idaho, USA. The deadline to apply is Monday, April 15, 2019. For more information including eligibility and to apply, please visit the ASBMR website.

 

NIAMS is Recruiting a Director - Applications Due April 30

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is recruiting a director to ensure that the late Dr. Stephen I. Katz’s commitment to outstanding arthritis and musculoskeletal and skin research continues. NIAMS seeks candidates who have a commitment to scientific excellence and the energy, enthusiasm, and innovative thinking necessary to lead a dynamic and diverse organization.  Applicants must possess an M.D., Ph.D., or equivalent doctoral degree in a relevant discipline. In addition, the incumbent must have experience and demonstrated ability in the administration and management of a major national research program as well as broad familiarity and working knowledge of arthritis and musculoskeletal and skin diseases research. The incumbent must possess in-depth knowledge and personal research experience in one or more of the NIAMS research areas. The scientific implications of the research programs will benefit from extensive experience and knowledge of federal research grants administration. Interested applicants should apply via USAJOBS. The deadline to apply is Tuesday, April 30.

 
JBMR® Highlights
Adding Marrow Adiposity and Cortical Porosity to Femoral Neck Areal Bone Mineral Density Improves the Discrimination of Women with Nonvertebral Fractures from Controls
Roger Zebaze, Marit Osima, Minh Bui, Marko Lukic, Xiaofang Wang, Ali Ghasem‐Zadeh, Erik F. Eriksen, Angela Vais, Catherine Shore‐Lorenti, Peter Ebeling, Ego Seeman, Åshild Bjørnerem
First Published: 18 March 2019
 
A new understanding of the role of IL‐1 in age‐related intervertebral disc degeneration in a murine model
Deborah J. Gorth, Irving M. Shapiro, Makarand V. Risbud
First Published: 15 March 2019
 
Effects of intravenous zoledronate on bone turnover and bone density persist for at least 11 years in HIV‐infected men
Mark J Bolland, Anne M Horne, Simon E Briggs, Mark G Thomas, Ian R Reid, Greg D Gamble, Andrew Grey
First Published: 14 March 2019
JBMR® Plus Highlights
The fracture callus is formed by progenitors of different skeletal origins in a site specific manner
Yongmei Wang, Ling Chen, Misun Kang, Lin Ling, Faming Tian, Sun Hee Won‐Kim, Sunita Ho, Daniel D. Bikle
First Published: 18 March 2019
 
FGF23, Hypophosphatemia, and Emerging Treatments
Erik A Imel, Andrew Biggin, Aaron Schindeler, Craig Munns
First Published: 18 March 2019
 
Denosumab treatment improved health‐related quality of life in osteoporosis‐a prospective cohort study
Shinya Hayashi, Koji Fukuda, Toshihisa Maeda, Nobuaki Chinzei, Shinsuke Kihara, Yasushi Miura, Yoshitada Sakai, Shingo Hashimoto, Tomoyuki Matsumoto, Koji Takayama, Takahiro Niikura, Ryosuke Kuroda
First Published: 15 March 2019
Bone Science in the News
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline 
Journal of Clinical Endocrinology (3/25/2019)
 
Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting
Daily Herald (3/23/2019)
 
Knowing causative genes of osteoporosis may open door to more effective treatments
News-Medical.net (3/22/2019)
 
Osteoporosis Medication Use After Hip Fracture
Physician’s Weekly (3/19/2019)
 
NICE guidance: fractures and quality of life in individuals with cerebral palsy
BMJ (3/19/2019)
 
Parathyroidectomy may decrease short-term CV risk markers in primary hyperparathyroidism
Endocrine today (3/19/2019)
 
First‐in‐Human Phase I Study of MBC‐11, a Novel Bone‐Targeted Cytarabine‐Etidronate Conjugate in Patients with Cancer‐Induced Bone Disease
The Oncologist (11/9/2018)
Events Calendar
March 27 - 29
MEN 2019: 16th International Workshop on Multiple Endocrine Neoplasia
Houston, TX, United States
 
April 4 – 7
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases 2019
Paris, France
 
April 15, 2019
NASEM Report Webinar - Sexual Harassment of Women: Climate, Culture, and Consequences in Academic Sciences, Engineering, and Medicine
Online webinar
 
April 18 - 21, 2019
SICEM 2019 - 7th Seoul International Congress of Endocrinology and Metabolism
Seoul, Korea
 
April 24 - 26, 2019
Network of Minority Health Research Investigators Annual Workshop
Bethesda, MD, United States
Contact ASBMR
ASBMR Business Office
2025 M Street, NW
Suite 800
Washington, DC 20036-3309 USA
Tel.: +1 (202) 367-1161
Fax: +1 (202) 367-2161
Email: asbmr@asbmr.org


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list